{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:05:07Z","timestamp":1780506307665,"version":"3.54.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03420-8","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:12:09Z","timestamp":1776723129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Smart In Situ-Forming Ocular Therapeutics for Dry Eye Disease: Bridging Biomaterials, Nanotechnology, and Clinical Translation"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3155-5736","authenticated-orcid":false,"given":"Adiba","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-8325","authenticated-orcid":false,"given":"Poonam","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8885-7795","authenticated-orcid":false,"given":"Bipasha","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2526-6138","authenticated-orcid":false,"given":"Sapna","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"3420_CR1","doi-asserted-by":"publisher","unstructured":"Yumei YL, Xinyue K, Bing RJ. Research progress of in-situ gelling ophthalmic drug delivery system. Asian J Pharm Sci. 2019.\u00a0https:\/\/doi.org\/10.1016\/j.ajps.2018.04.008.","DOI":"10.1016\/j.ajps.2018.04.008"},{"key":"3420_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3705-y","author":"M Belyhun","year":"2018","unstructured":"Belyhun M, Endris M, Asmare A. Ocular bacterial infections and antibiotic resistance patterns in patients attending Gondar Teaching Hospital, Northwest Ethiopia. BMC Res Notes. 2018. https:\/\/doi.org\/10.1186\/s13104-018-3705-y.","journal-title":"BMC Res Notes"},{"key":"3420_CR3","doi-asserted-by":"crossref","unstructured":"Vidal-Rohr, Craig, Davies, Wolffsohn. Classification of dry eye disease subtypes. Contact Lens and Anterior Eye. 2024 Oct 1;47(5):102257.","DOI":"10.1016\/j.clae.2024.102257"},{"key":"3420_CR4","doi-asserted-by":"publisher","unstructured":"Lifei Y, Chunjing Y, He D, Yanan M, Rui Z, Qiaosi Z, et al. Recent developments about the pathogenesis of dry eye disease: based on immune inflammatory mechanisms. Front Pharmacol. 2021 Aug 5;12:732887. https:\/\/doi.org\/10.3389\/fphar.2021.732887.","DOI":"10.3389\/fphar.2021.732887"},{"key":"3420_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114582","author":"N Noriaki","year":"2022","unstructured":"Noriaki N, Hiroko O. Novel drug delivery systems for the management of dry eye. Adv Drug Deliv Rev. 2022. https:\/\/doi.org\/10.1016\/j.addr.2022.114582.","journal-title":"Adv Drug Deliv Rev"},{"key":"3420_CR6","doi-asserted-by":"crossref","unstructured":"Pei-Hsuan L, Hong-Jyuan, Yu-Jia L, Yu-Fen H, Anand, Chih-Ching H, et al. Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels. Acta Biomaterialia. 2022 Mar 15;141:140\u201350.","DOI":"10.1016\/j.actbio.2022.01.044"},{"key":"3420_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030990","author":"H Mondal","year":"2023","unstructured":"Mondal H, Ho-Joong K, Mohanto N, Jun-Pil J. A review on dry eye disease treatment: recent progress, diagnostics, and future perspectives. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15030990.","journal-title":"Pharmaceutics"},{"key":"3420_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2023.04.004","author":"JS Wolffsohn","year":"2023","unstructured":"Wolffsohn JS, Lingham G, Downie LE, Huntjens B, Takenori I, Jivraj S, et al. TFOS Lifestyle: Impact of the digital environment on the ocular surface. Ocul Surf. 2023. https:\/\/doi.org\/10.1016\/j.jtos.2023.04.004.","journal-title":"Ocul Surf"},{"key":"3420_CR9","doi-asserted-by":"crossref","unstructured":"Munoz-Villegas, Garcia-Sanchez G, Jauregui-Franco RO, Quirarte-Justo, Sanchez-Rios, Olvera-Montano O. Influence of environmental factors with clinical signs and symptoms in the management of dry eye disease. Clin Ophthalmol. 2024.","DOI":"10.2147\/OPTH.S480223"},{"issue":"6","key":"3420_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61060976","volume":"61","author":"MA Jareebi","year":"2025","unstructured":"Jareebi MA, Akkur AA, Otayf DAH, Najmi AY, Mobarki OA, Omar EZ, et al. Exploring the prevalence of dry eye disease and its impact on quality of life in Saudi adults: a cross-sectional investigation. Medicina (Kaunas). 2025;61(6):976.","journal-title":"Medicina (Kaunas)"},{"key":"3420_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.06.033","author":"KF Farrand","year":"2017","unstructured":"Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017. https:\/\/doi.org\/10.1016\/j.ajo.2017.06.033.","journal-title":"Am J Ophthalmol"},{"key":"3420_CR12","doi-asserted-by":"publisher","unstructured":"S, Ali T. Chromatography and spectroscopic technique-based rapid characterization of nano-carrier pharmaceuticals. Pharm Nanotechnol. 2024 Oct 21. https:\/\/doi.org\/10.2174\/0122117385319695240911115239.","DOI":"10.2174\/0122117385319695240911115239"},{"key":"3420_CR13","doi-asserted-by":"publisher","unstructured":"Hongyun L, Shengliang Z, Jinling W, Qihe C. A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front Nutr. 2021 Dec 1;8:783831. https:\/\/doi.org\/10.3389\/fnut.2021.783831.","DOI":"10.3389\/fnut.2021.783831"},{"key":"3420_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/nano12081376","author":"A Crintea","year":"2022","unstructured":"Crintea A, Dutu AG, Sovrea A, Constantin AM, Samasca G, Masalar AL, et al. Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation. Nanomaterials. 2022. https:\/\/doi.org\/10.3390\/nano12081376.","journal-title":"Nanomaterials"},{"key":"3420_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102868","author":"DK Sahu","year":"2021","unstructured":"Sahu DK, Pradhan D, Biswasroy P, Kar B, Ghosh G, Rath G. Recent trends in nanocarrier based approach in the management of dry eye disease. J Drug Deliv Sci Technol. 2021. https:\/\/doi.org\/10.1016\/j.jddst.2021.102868.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3420_CR16","unstructured":"Mohanty D, Bakshi DV, Simharaju N, Haque MA, Sahoo CK. A review on in situ gel: a novel drug delivery system. Int J Pharm Sci Rev Res. 2018;50(1):175\u2013181."},{"key":"3420_CR17","doi-asserted-by":"publisher","unstructured":"Ghenciu LA, Hategan OA, Stoicescu ER, Iacob, Sisu AM. Emerging therapeutic approaches and genetic insights in stargardt disease: a comprehensive review. Int J Mol Sci. 2024 Aug; 25(16); https:\/\/doi.org\/10.3390\/ijms25168859.","DOI":"10.3390\/ijms25168859"},{"key":"3420_CR18","doi-asserted-by":"publisher","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular drug delivery: a comprehensive review. AAPS PharmSciTech. 2023 Feb 14;24(2):66. https:\/\/doi.org\/10.1208\/s12249-023-02516-9.","DOI":"10.1208\/s12249-023-02516-9"},{"key":"3420_CR19","doi-asserted-by":"crossref","unstructured":"Shamanna M, M KK. Expert opinion on the prescription practice of artificial tear formulations for the management of dry eye disease in Indian settings: a questionnaire-based survey. Indian J Clin Exp Opthalmol. 2024;10(3):554\u2013559.","DOI":"10.18231\/j.ijceo.2024.096"},{"key":"3420_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020207","author":"P Agarwal","year":"2021","unstructured":"Agarwal P, Craig JP, Rupenthal ID. Formulation considerations for the management of dry eye disease. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13020207.","journal-title":"Pharmaceutics"},{"issue":"14","key":"3420_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201908476","volume":"30","author":"NH Bennett","year":"2020","unstructured":"Bennett NH, Chinnery HR, Downie LE, Hill LJ, Grover LM. Material, immunological, and practical perspectives on eye drop formulation. Adv Funct Mater. 2020;30(14):1908476.","journal-title":"Adv Funct Mater"},{"key":"3420_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2018.1517741","author":"F Zahir-Jouzdani","year":"2018","unstructured":"Zahir-Jouzdani F, Wolf JD, Atyabi F, Bernkop-Schnurch A. In situ gelling and mucoadhesive polymers: why do they need each other? Expert Opin Drug Deliv. 2018. https:\/\/doi.org\/10.1080\/17425247.2018.1517741.","journal-title":"Expert Opin Drug Deliv"},{"key":"3420_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/pol.20210907","author":"V Ow","year":"2022","unstructured":"Ow V, Xian Jun L. Recent developments of temperature-responsive polymers for ophthalmic applications. J Polym Sci. 2022. https:\/\/doi.org\/10.1002\/pol.20210907.","journal-title":"J Polym Sci"},{"key":"3420_CR24","doi-asserted-by":"publisher","DOI":"10.1039\/d3lp00114h","author":"Y Yichan","year":"2023","unstructured":"Yichan Y, Konpal R, Milbrandt NB, Beilharz S, Tene S, Oshabaheebwa S, et al. Thermoresponsive polymers with LCST transition: synthesis, characterization, and their impact on biomedical frontiers. RSC Applied Polymers. 2023. https:\/\/doi.org\/10.1039\/d3lp00114h.","journal-title":"RSC Applied Polymers"},{"key":"3420_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.12.017","author":"AA Al-Kinani","year":"2018","unstructured":"Al-Kinani AA, Zidan G, Elsaid N, Seyfoddin A, Alani AWG, Alany RG. Ophthalmic gels: past, present and future. Adv Drug Deliv Rev. 2018. https:\/\/doi.org\/10.1016\/j.addr.2017.12.017.","journal-title":"Adv Drug Deliv Rev"},{"key":"3420_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.reactfunctpolym.2022.105282","author":"H Musarurwa","year":"2022","unstructured":"Musarurwa H, Tavengwa NT. Stimuli-responsive polymers and their applications in separation science. React Funct Polym. 2022. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2022.105282.","journal-title":"React Funct Polym"},{"key":"3420_CR27","doi-asserted-by":"publisher","unstructured":"Hasnain MS, Ahmad SA, Hoda MN, Rishishwar S, Rishishwar P, Nayak AK. Stimuli-responsive carbon nanotubes for targeted drug delivery. Stimuli responsive polymeric nanocarriers for drug delivery applicatons. 2019;321\u2013344. https:\/\/doi.org\/10.1016\/B978-0-08-101995-5.00015-5.","DOI":"10.1016\/B978-0-08-101995-5.00015-5"},{"key":"3420_CR28","doi-asserted-by":"publisher","unstructured":"Minqi Z, Jing W, Na L. A novel thermo-sensitive hydrogel-based on poly(N-isopropylacrylamide)\/hyaluronic acid of ketoconazole for ophthalmic delivery. Artif Cells Nanomed Biotechnol. 2018. https:\/\/doi.org\/10.1080\/21691401.2017.1368024.","DOI":"10.1080\/21691401.2017.1368024"},{"key":"3420_CR29","doi-asserted-by":"publisher","unstructured":"Jumelle, Gholizadeh, Annabi, Dana. Advances and limitations of drug delivery systems formulated as eye drops. J Control Release. 2020 May 10;321:1\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.057.","DOI":"10.1016\/j.jconrel.2020.01.057"},{"key":"3420_CR30","doi-asserted-by":"publisher","DOI":"10.1039\/C8TB02976H","author":"E Bellotti","year":"2019","unstructured":"Bellotti E, Fedorchak MV, Velankar S, Little SR. Tuning of thermoresponsive pNIPAAm hydrogels for the topical retention of controlled release ocular therapeutics. J Mater Chem B. 2019. https:\/\/doi.org\/10.1039\/C8TB02976H.","journal-title":"J Mater Chem B"},{"key":"3420_CR31","doi-asserted-by":"publisher","unstructured":"Debby C, Kinam P, Amin F. Hydrogels for sustained delivery of biologics to the back of the eye. Drug Discov Today. 2019. https:\/\/doi.org\/10.1016\/j.drudis.2019.05.037.","DOI":"10.1016\/j.drudis.2019.05.037"},{"key":"3420_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-018-0504-x","author":"M Kabiri","year":"2018","unstructured":"Kabiri M, Kamal SH, Pawar SV, Roy PR, Derakhshandeh M, Kumar U, et al. A stimulus-responsive, in situ-forming, nanoparticle-laden hydrogel for ocular drug delivery. Drug Deliv Transl Res. 2018. https:\/\/doi.org\/10.1007\/s13346-018-0504-x.","journal-title":"Drug Deliv Transl Res"},{"issue":"10","key":"3420_CR33","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1248\/cpb.c14-00451","volume":"62","author":"J Li","year":"2014","unstructured":"Li J, Liu H, Liu LL, Cai CN, Xin HX, Liu W. Design and evaluation of a brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery. Chem Pharm Bull (Tokyo). 2014;62(10):1000\u20138.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"3420_CR34","doi-asserted-by":"crossref","unstructured":"Han Y, Jiang L, Shi H, Xu C, Liu M, Li Q, et al. Effectiveness of an ocular adhesive polyhedral oligomeric silsesquioxane hybrid thermo-responsive FK506 hydrogel in a murine model of dry eye. Bioact Mater. 2021;28(9):77\u201391.","DOI":"10.1016\/j.bioactmat.2021.07.027"},{"key":"3420_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120591","author":"L Xueqi","year":"2021","unstructured":"Xueqi L, Xingdi W, Xiang C, Ben W, Wen X. Intellective and stimuli-responsive drug delivery systems in eyes. Int J Pharm. 2021. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120591.","journal-title":"Int J Pharm"},{"key":"3420_CR36","doi-asserted-by":"publisher","DOI":"10.1039\/D0PY00919A","author":"DD Nguyen","year":"2020","unstructured":"Nguyen DD, Lai JY. Advancing the stimuli response of polymer-based drug delivery systems for ocular disease treatment. Polym Chem. 2020. https:\/\/doi.org\/10.1039\/D0PY00919A.","journal-title":"Polym Chem"},{"key":"3420_CR37","doi-asserted-by":"crossref","unstructured":"Dludla SB, Mashabela LT, Ng\u2019andwe B, Makoni PA, Witika BA. Current advances in nano-based and polymeric stimuli-responsive drug delivery targeting the ocular microenvironment: a review and envisaged future perspectives. Polymers. 2022;14(17):3580.","DOI":"10.3390\/polym14173580"},{"key":"3420_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2021.100031","author":"M Yongxu","year":"2021","unstructured":"Yongxu M, Lidong G, Tianjiao P, Jun Y, Zhiqiang L. Advances in pH-responsive drug delivery systems. Open Nano. 2021. https:\/\/doi.org\/10.1016\/j.onano.2021.100031.","journal-title":"Open Nano"},{"key":"3420_CR39","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v11i6-S.5147","author":"M Singh","year":"2021","unstructured":"Singh M, Dev D, Prasad DN. A recent overview: in situ gel smart carriers for ocular drug delivery. J Drug Deliv Ther. 2021. https:\/\/doi.org\/10.22270\/jddt.v11i6-S.5147.","journal-title":"J Drug Deliv Ther"},{"key":"3420_CR40","doi-asserted-by":"publisher","DOI":"10.25258\/ijddt.v8i01.11900","author":"IS Kurniawansyah","year":"2018","unstructured":"Kurniawansyah IS, Rahmi F, Sopyan I. pH triggered in-situ gelling ophthalmic drug delivery system. Int J Drug Deliv Technol. 2018. https:\/\/doi.org\/10.25258\/ijddt.v8i01.11900.","journal-title":"Int J Drug Deliv Technol"},{"key":"3420_CR41","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1431-y","author":"M Kouchak","year":"2019","unstructured":"Kouchak M, Mahmoodzadeh M, Farrahi F. Designing of a pH-triggered Carbopol\u00ae\/HPMC in situ gel for ocular delivery of Dorzolamide HCl: in vitro, in vivo, and ex vivo evaluation. AAPS PharmSciTech. 2019. https:\/\/doi.org\/10.1208\/s12249-019-1431-y.","journal-title":"AAPS PharmSciTech"},{"key":"3420_CR42","doi-asserted-by":"publisher","unstructured":"Zhu Q, Liu C, Sun Z, Zhang X, Liang N, Mao S. Inner layer-embedded contact lenses for pH-triggered controlled ocular drug delivery. Eur J Pharm Biopharm. 2018. https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.017.","DOI":"10.1016\/j.ejpb.2018.04.017"},{"key":"3420_CR43","doi-asserted-by":"publisher","unstructured":"Arruebo M, Sebastian V. Batch and microfluidic reactors in the synthesis of enteric drug carriers. In: Arruebo M, Sebastian V, eds. Nanotechnology for oral drug delivery. 2020. p. 317\u2013357. https:\/\/doi.org\/10.1016\/b978-0-12-818038-9.00008-9.","DOI":"10.1016\/b978-0-12-818038-9.00008-9"},{"key":"3420_CR44","doi-asserted-by":"crossref","unstructured":"Ruo-Chen G, Xue-Hao Z, Peng-Sheng F, Ben-Li S, Zhi-Xiang L, Zhong-Yu D, et al. In vivo self-assembly induced cell membrane phase separation for improved peptide drug internalization. Angew Chem Int Ed Engl. 2021 Nov;60(47):25128\u201325134.","DOI":"10.1002\/anie.202111839"},{"key":"3420_CR45","doi-asserted-by":"publisher","unstructured":"Man-Di, Da-Yong H, Gan-Tian L, R-Xiang L, Xing-Jie H, Zhi-Jia W, et al. Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency. Biomaterials. 2021 Nov;278:121139. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121139.","DOI":"10.1016\/j.biomaterials.2021.121139"},{"issue":"344","key":"3420_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jconrel.2022.03.011","volume":"1","author":"Y Hu","year":"2022","unstructured":"Hu Y, Wang Y, Deng J, Ding X, Lin D, Shi H, Chen L, Lin D, Wang Y, Vakal S, Wang J. Enzyme-instructed self-assembly of peptide-drug conjugates in tear fluids for ocular drug delivery. J Control Release. 2022;1(344):261\u201371.","journal-title":"J Control Release"},{"key":"3420_CR47","doi-asserted-by":"crossref","unstructured":"Grimaudo MA, Pescina S, Padula C, Santi P, Concheiro A, Alvarez-Lorenzo C, et al. Poloxamer 407\/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery. Mol Pharm. 2018;15(2):571\u201384.","DOI":"10.1021\/acs.molpharmaceut.7b00939"},{"key":"3420_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/polym12061397","author":"SS Das","year":"2020","unstructured":"Das SS, Bharadwaj P, Bilal M, Barani M, Rahdar A, Taboada P, et al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers. 2020. https:\/\/doi.org\/10.3390\/polym12061397.","journal-title":"Polymers"},{"key":"3420_CR49","doi-asserted-by":"crossref","unstructured":"Tao Z, Zichao L. Stimulus-responsive nanomaterials for ocular antimicrobial therapy. R Soc Chem. 2025 May;22:13653\u201316667.","DOI":"10.1039\/D4NR05462H"},{"key":"3420_CR50","doi-asserted-by":"publisher","unstructured":"Elbedwehy AM, Jun W, Hee-Kang N, Ahruem B, Haejin J, Ik Hwon K, et al. ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases. J Control Release. 2024. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.022.","DOI":"10.1016\/j.jconrel.2024.07.022"},{"issue":"6","key":"3420_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202307569","volume":"34","author":"Z Chen","year":"2024","unstructured":"Chen Z, Li Z, Tang N, Huang Y, Li S, Xu W, et al. Engineering ultra\u2010small cerium\u2010based metal\u2013organic frameworks nanozymes for efficient antioxidative treatment of dry eye disease. Adv Funct Mater. 2024;34(6):2307569.","journal-title":"Adv Funct Mater"},{"key":"3420_CR52","doi-asserted-by":"publisher","unstructured":"Hailing Y, Xinxi Y, Yin H, Ting Y, Huimin L, Qianqian Z, et al. Engineering biocompatible carbon dots nano-enzymes hydrogel for efficient antioxidative and anti-inflammatory treatment of dry eye disease. J Control Release. 2025 May 10;381:113490. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.081.","DOI":"10.1016\/j.jconrel.2025.01.081"},{"key":"3420_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030269","author":"R Varela-Fernandez","year":"2020","unstructured":"Varela-Fernandez R, Diaz-Tome V, Luaces-Rodriguez A, Condo-Penedo A, Garcia-Otero X, Luzardo-Rodriguez A, et al. Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12030269.","journal-title":"Pharmaceutics"},{"key":"3420_CR54","doi-asserted-by":"publisher","unstructured":"Raza A, Rasheed T, Nabeel, Hayat, Bilal, Iqbal HMN. Endogenous and exogenous stimuli-responsive drug delivery systems for programmed site-specific release. Molecules. 2019 Mar 21;24(6):1117. https:\/\/doi.org\/10.3390\/molecules24061117.","DOI":"10.3390\/molecules24061117"},{"key":"3420_CR55","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c17-00068","author":"H H","year":"2017","unstructured":"H H. Recent advances in endogenous and exogenous stimuli-responsive nanocarriers for drug delivery and therapeutics. Chem Pharm Bull. 2017. https:\/\/doi.org\/10.1248\/cpb.c17-00068.","journal-title":"Chem Pharm Bull"},{"key":"3420_CR56","doi-asserted-by":"publisher","DOI":"10.1039\/c8py01174e","author":"D Yu","year":"2019","unstructured":"Yu D, Xin C, Xiaojin Z. Recent advances in stimuli-responsive polymeric micelles via click chemistry. Polymer Chemistry. 2019. https:\/\/doi.org\/10.1039\/c8py01174e.","journal-title":"Polymer Chemistry"},{"issue":"4","key":"3420_CR57","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1111\/aos.13526","volume":"96","author":"S Seen","year":"2018","unstructured":"Seen S, Tong L. Dry eye disease and oxidative stress. Acta Ophthalmol. 2018;96(4):e412-20.","journal-title":"Acta Ophthalmol"},{"key":"3420_CR58","doi-asserted-by":"crossref","unstructured":"Dogru M, Kojima T, Simsek C, Tsubota K. Potential role of oxidative stress in ocular surface inflammation and dry eye disease. Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES163\u20138.","DOI":"10.1167\/iovs.17-23402"},{"key":"3420_CR59","doi-asserted-by":"crossref","unstructured":"Yu-Jia L, Li-Jyuan L, Harroun SG, Shih-Chun W, Unnikrishnan, Huan-Tsung C, et al. Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease. Nanoscale. 2019 March; 11(12):5580\u20135594.","DOI":"10.1039\/C9NR00376B"},{"key":"3420_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/gels9040292","author":"W Yongkang","year":"2023","unstructured":"Yongkang W, Qing T, Xie J, Lili L, Xiuli X, Yang Z, et al. Advances in nanogels for topical drug delivery in ocular diseases. Gels. 2023. https:\/\/doi.org\/10.3390\/gels9040292.","journal-title":"Gels"},{"key":"3420_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.01.040","author":"L Liu","year":"2025","unstructured":"Liu L, Yifei C, Yong D, Xin W, Qiumeng C, Yuxi Y, et al. Fluorinated multifunctional polymer vesicles for enhanced ocular surface penetration and synergistic treatment of dry eye disease. J Control Release. 2025. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.040.","journal-title":"J Control Release"},{"key":"3420_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/polym13081340","author":"M Pandey","year":"2021","unstructured":"Pandey M, Choudhury H, Aziz ABA, bhattamisra SK, Gorain B, Jocelyn Sziou Ting S, et al. Potential of stimuli-responsive in situ gel system for sustained ocular drug delivery: recent progress and contemporary research. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13081340.","journal-title":"Polymers"},{"key":"3420_CR63","doi-asserted-by":"publisher","DOI":"10.2174\/1872211314666200108094851","author":"S Gorantla","year":"2019","unstructured":"Gorantla S, Waghule T, Rapali VK, Singh PP, Dubay SK, Saha RN, et al. Advanced Hydrogels Based Drug Delivery Systems for Ophthalmic Delivery. Recent Patents on Drug Delivery & Formulation. 2019. https:\/\/doi.org\/10.2174\/1872211314666200108094851.","journal-title":"Recent Patents on Drug Delivery & Formulation"},{"issue":"93","key":"3420_CR64","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.msec.2018.07.065","volume":"1","author":"Q Zhu","year":"2018","unstructured":"Zhu Q, Wei Y, Li C, Mao S. Inner layer-embedded contact lenses for ion-triggered controlled drug delivery. Mater Sci Eng C Mater Biol Appl. 2018;1(93):36\u201348.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"3420_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.12.028","author":"V Diaz-Tome","year":"2018","unstructured":"Diaz-Tome V, Luaces-Rodriguez A, Silva-Rodriguez J, Blanco-Dorado S, Garcia-Quintanilla L, Llovo-Taboada J, et al. Ophthalmic econazole hydrogels for the treatment of fungal keratitis. J Pharm Sci. 2018. https:\/\/doi.org\/10.1016\/j.xphs.2017.12.028.","journal-title":"J Pharm Sci"},{"key":"3420_CR66","doi-asserted-by":"crossref","unstructured":"Omidian H, Akhzarmehr A, Gill EJ. Cyclodextrin-hydrogel hybrids in advanced drug delivery. Gels. 2025;11(3):177.","DOI":"10.3390\/gels11030177"},{"key":"3420_CR67","doi-asserted-by":"crossref","unstructured":"Li Q, Cao Y, Wang P. Recent advances in hydrogels for the diagnosis and treatment of dry eye disease. Gels. 2022;8(12):816.","DOI":"10.3390\/gels8120816"},{"key":"3420_CR68","doi-asserted-by":"publisher","unstructured":"Kasinski A, Zielinska-Pisklak, Oledzka, Sobczak. Smart hydrogels \u2013 synthetic stimuli-responsive antitumor drug release systems. Int J Nanomed. 2020 Jun 25;15:4541\u20134572. https:\/\/doi.org\/10.2147\/IJN.S248987.","DOI":"10.2147\/IJN.S248987"},{"key":"3420_CR69","doi-asserted-by":"publisher","unstructured":"Yumei W, Yuanyuan L, Xinye L, Kebebe D, Bing Z, Ren J, et al. Research progress of in-situ gelling ophthalmic drug delivery system. Asian J Pharm Sci. 2019 Jan;14(1):1\u201315. https:\/\/doi.org\/10.1016\/j.ajps.2018.04.008.","DOI":"10.1016\/j.ajps.2018.04.008"},{"key":"3420_CR70","doi-asserted-by":"crossref","unstructured":"Baig MS, Karade SK, Ahmad A, Khan MA, Haque A, Webster TJ, et al. Lipid-based nanoparticles: innovations in ocular drug delivery. Front Mol Biosci. 2024;11:1421959.","DOI":"10.3389\/fmolb.2024.1421959"},{"key":"3420_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138979","volume":"290","author":"S Biswal","year":"2025","unstructured":"Biswal S, Parmanik A, Das D, Sahoo RN, Nayak AK. Gellan gum-based in-situ gel formulations for ocular drug delivery: A practical approach. Int J Biol Macromol. 2025;290: 138979.","journal-title":"Int J Biol Macromol."},{"key":"3420_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.02.027","author":"KA Khateb","year":"2016","unstructured":"Khateb KA, Ozhmukhametova EK, Mussin MN, Seilkhanov SK, Rakhypbekov TK, Man W, et al. In situ gelling systems based on Pluronic F127\/Pluronic F68 formulations for ocular drug delivery. Int J Pharm. 2016. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.02.027.","journal-title":"Int J Pharm"},{"key":"3420_CR73","doi-asserted-by":"crossref","unstructured":"Morsi, Ghorab D, Refai H, Teba H. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm. 2016 June; 506(1-2): 57\u201367.","DOI":"10.1016\/j.ijpharm.2016.04.021"},{"issue":"2","key":"3420_CR74","first-page":"S96","volume":"50","author":"AP Gadad","year":"2016","unstructured":"Gadad AP, Wadklar PD, Dandghi P, Patil A. Thermosensitive In situ Gel for Ocular Delivery of Lomefloxacin. Indian J Pharm Educ Res. 2016;50(2):S96\u2013107.","journal-title":"Indian J Pharm Educ Res"},{"issue":"11","key":"3420_CR75","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3109\/03639041003801893","volume":"36","author":"Y Qian","year":"2010","unstructured":"Qian Y, Wang F, Li R, Zhang Q, Xu Q. Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide. Drug Dev Ind Pharm. 2010;36(11):1340\u20137.","journal-title":"Drug Dev Ind Pharm."},{"key":"3420_CR76","doi-asserted-by":"crossref","unstructured":"Asasutjarit R, Thanasanchokpibull S, Fuongfuchat A, Veeranondha S. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. Int J Pharm. 2011;411(1\u20132):128\u201335.","DOI":"10.1016\/j.ijpharm.2011.03.054"},{"issue":"11","key":"3420_CR77","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3109\/03639041003801885","volume":"36","author":"HO Ammar","year":"2010","unstructured":"Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm. 2010;36(11):1330\u20139.","journal-title":"Drug Dev Ind Pharm"},{"key":"3420_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.rinphs.2015.06.001","author":"SB Makwana","year":"2016","unstructured":"Makwana SB, Patel VA, Parmar SJ. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results in Pharma Sciences. 2016. https:\/\/doi.org\/10.1016\/j.rinphs.2015.06.001.","journal-title":"Results in Pharma Sciences"},{"key":"3420_CR79","doi-asserted-by":"crossref","unstructured":"Kumara BN, Shambhu, Yoon-Bo S, Prasad KS. Lysozyme activated co-delivery of latanoprost\u2013timolol from mucoadhesive chitosan nanocomposite to manage glaucoma. R Soc Chem Pharm. 2024;1(3):548\u201369.","DOI":"10.1039\/D4PM00031E"},{"issue":"3","key":"3420_CR80","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/10837450.2017.1328693","volume":"23","author":"X Pang","year":"2018","unstructured":"Pang X, Li J, Pi J, Qi D, Guo P, Li N, et al. Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits. Pharm Dev Technol. 2018;23(3):231\u20139.","journal-title":"Pharm Dev Technol."},{"issue":"3","key":"3420_CR81","first-page":"S616","volume":"17","author":"AA Sheikh","year":"2017","unstructured":"Sheikh AA, Sheikh SR, Admane SS. Development and characterization of novel in situ gel of moxifloxacin hydrochloride. Asian J Pharm. 2017;17(3):S616\u201324.","journal-title":"Asian J Pharm"},{"key":"3420_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.110681","author":"SS Pandey","year":"2020","unstructured":"Pandey SS, Maulvi FA, Patel PS, Shukla MR, Shah KM, Gupta AR, et al. Cyclosporine laden tailored microemulsion-gel depot for effective treatment of psoriasis: In vitro and in vivo studies. Colloids Surf B Biointerfaces. 2020. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110681.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3420_CR83","doi-asserted-by":"crossref","unstructured":"Najafi M, Asadi H, Van Den Dikkenberg J, Van Steenbergen MJ, Fens MH, Hennink WE, et al. Conversion of an injectable MMP-degradable hydrogel into core-cross-linked micelles. Biomacromol. 2020;21(5):1739\u201351.","DOI":"10.1021\/acs.biomac.9b01675"},{"issue":"18","key":"3420_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/nano12183183","volume":"12","author":"HF Abed","year":"2022","unstructured":"Abed HF, Abuwatfa WH, Husseini GA. Redox-responsive drug delivery systems: a chemical perspective. Nanomaterials (Basel). 2022;12(18):3183. https:\/\/doi.org\/10.3390\/nano12183183.","journal-title":"Nanomaterials (Basel)"},{"key":"3420_CR85","doi-asserted-by":"publisher","unstructured":"Xiang Y, Qiu Z, Ding Y, Du M, Gao N, Cao H, Zuo H, Cheng H, Gao X, Zheng S, Wan W, Huang X, Hu K. Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization. J Control Release. 2024 Aug;372:874\u2013884. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.012.","DOI":"10.1016\/j.jconrel.2024.07.012"},{"issue":"12","key":"3420_CR86","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1007\/s13346-022-01155-0","volume":"12","author":"P Khare","year":"2022","unstructured":"Khare P, Chogale MM, Kakade P, Patravale VB. Gellan gum-based in situ gelling ophthalmic nanosuspension of posaconazole. Drug Deliv Transl Res. 2022;12(12):2920\u201335. https:\/\/doi.org\/10.1007\/s13346-022-01155-0.","journal-title":"Drug Deliv Transl Res"},{"key":"3420_CR87","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.actbio.2022.01.044","volume":"141","author":"PH Lin","year":"2022","unstructured":"Lin PH, Jian HJ, Li YJ, Huang YF, Anand A, Huang CC, et al. Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels. Acta Biomater. 2022;141:140\u201350.","journal-title":"Acta Biomater."},{"key":"3420_CR88","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000636","author":"J Sheppard","year":"2020","unstructured":"Sheppard J, Kannarr S, Luchs J, Malhotra R, Justice A, Ogundele A, et al. Efficacy and safety of OTX-101, a novel nanomicellar formulation of cyclosporine A, for the treatment of keratoconjunctivitis sicca: pooled analysis of a phase 2b\/3 and phase 3 study. Eye Contact Lens. 2020. https:\/\/doi.org\/10.1097\/ICL.0000000000000636.","journal-title":"Eye Contact Lens"},{"key":"3420_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/bios13100933","author":"NL Kazanskiy","year":"2023","unstructured":"Kazanskiy NL, Khonina SN, Butt MA. Smart contact lenses\u2014a step towards non-invasive continuous eye health monitoring. Biosensors. 2023. https:\/\/doi.org\/10.3390\/bios13100933.","journal-title":"Biosensors"},{"key":"3420_CR90","doi-asserted-by":"publisher","unstructured":"Jang J, Kim J, Shin H, Park YG, Joo BJ, Seo H, Won JE, Kim DW, Lee CY, Kim HK, Park JU. Smart contact lens and transparent heat patch for remote monitoring and therapy of chronic ocular surface inflammation using mobiles. Sci Adv. 2021 Mar 31;7(14):eabf7194. https:\/\/doi.org\/10.1126\/sciadv.abf7194.","DOI":"10.1126\/sciadv.abf7194"},{"key":"3420_CR91","doi-asserted-by":"crossref","unstructured":"Yi W, Tong L, Yangfeng L, Rong Y, Guangyu Z. 2D-materials-based wearable biosensor systems. Biosensers. 2022 October;12(11):936\u2013952.","DOI":"10.3390\/bios12110936"},{"key":"3420_CR92","doi-asserted-by":"crossref","unstructured":"Kevin Y, Dave, Carbonneau, Tran SD. Smart contact lenses in ophthalmology: innovations, applications, and future prospects. Micromachines. 2024 June;15(7):1\u201317.","DOI":"10.3390\/mi15070856"},{"key":"3420_CR93","doi-asserted-by":"crossref","unstructured":"Graham AD, Kothapalli T, Jiayun W, Asbell PA, Stella XY, Meng CL. A machine learning approach to predicting dry eye-related signs, symptoms and diagnoses from meibography images. Heliyon. 2024;10(17):e36021.","DOI":"10.1016\/j.heliyon.2024.e36021"},{"key":"3420_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114817","volume":"196","author":"TY Kim","year":"2023","unstructured":"Kim TY, Lee GH, Mun J, Cheong S, Choi I, Kim H, et al. Smart contact lens systems for ocular drug delivery and therapy. Adv Drug Deliv Rev. 2023;196: 114817.","journal-title":"Adv Drug Deliv Rev."},{"issue":"9","key":"3420_CR95","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1021\/acsabm.3c00296","volume":"6","author":"K Ishihara","year":"2023","unstructured":"Ishihara K, Shi X, Fukazawa K, Yamaoka T, Yao G, Wu JY. Biomimetic-engineered silicone hydrogel contact lens materials. ACS Appl Bio Mater. 2023;6(9):3600\u201316.","journal-title":"ACS Appl Bio Mater"},{"key":"3420_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091421","author":"X Xiaoyan","year":"2021","unstructured":"Xiaoyan X, Awwad S, Diaz-Gomez L, Alvarez-Lorenzo C, Brocchini S, Gaisford S, et al. 3D printed punctal plugs for controlled ocular drug delivery. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13091421.","journal-title":"Pharmaceutics"},{"key":"3420_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2019.11.010","author":"L KangJu","year":"2020","unstructured":"KangJu L, Marcus JG, Tebon P, Wujin S, Zhimin L, Junmin L, et al. Non-transdermal microneedles for advanced drug delivery. Adv Drug Deliv Rev. 2020. https:\/\/doi.org\/10.1016\/j.addr.2019.11.010.","journal-title":"Adv Drug Deliv Rev"},{"key":"3420_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116907","author":"P Gupta","year":"2019","unstructured":"Gupta P, Yadav KS. Applications of microneedles in delivering drugs for various ocular diseases. Life Sci. 2019. https:\/\/doi.org\/10.1016\/j.lfs.2019.116907.","journal-title":"Life Sci"},{"key":"3420_CR99","doi-asserted-by":"crossref","unstructured":"Mingyue C, Mengjia Z, Wiraja C, Sharon Wan Ting C, Mishra A, Mayandi V, et al. Ocular delivery of predatory bacteria with cryomicroneedles against eye infection. Adv Sci. 2021 Nov; 8(21):e2102327.","DOI":"10.1002\/advs.202102327"},{"key":"3420_CR100","unstructured":"Hui S, Jianhong Z, Yuan W, Yutuo Z, Deqing L, Lei L, et al. A rapid corneal healing microneedle for efficient ocular drug delivery. Small. 2022."},{"key":"3420_CR101","doi-asserted-by":"crossref","unstructured":"KangJu L, SeungHyun P, Dong Hyun J, Chang Sik C, Ha Young J, Jiyeon, et al. Self-Plugging Microneedle (SPM) for intravitreal drug delivery. Adv Healthc Mater. 2022 June; 11(12): e2102599.","DOI":"10.1002\/adhm.202270068"},{"key":"3420_CR102","doi-asserted-by":"crossref","unstructured":"Bin K, Rui L, Xiaojun H, Meiyan L, Xingtao Z, Yuanjin Z, et al. Cornea-inspired ultrasound-responsive adhesive hydrogel patches for keratitis treatment. Adv Funct Mater. 2024 Mar;34(12):2310544.","DOI":"10.1002\/adfm.202310544"},{"key":"3420_CR103","doi-asserted-by":"crossref","unstructured":"Nichols FR, Nguyen MT, Ekpenyong , Pade KH. Point-of-care ultrasound assessment of orbital rhabdomyosarcoma in a pediatric patient. Pediatr Emerg Care. 2022 July;38(7):339\u2013341.","DOI":"10.1097\/PEC.0000000000002761"},{"key":"3420_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.mattod.2022.12.004","author":"Z Zhenyu","year":"2023","unstructured":"Zhenyu Z, Qimanguli S, Zhengwei C, Ming C, Wenguo C. Ultrasound technology and biomaterials for precise drug therapy. Mater Today. 2023 Mar 1;63:210\u201338.\u00a0https:\/\/doi.org\/10.1016\/j.mattod.2022.12.004.","journal-title":"Mater Today"},{"key":"3420_CR105","doi-asserted-by":"crossref","unstructured":"Younghoon P, Jaewoo S, Junwon P, Seulbi K, Ji Hun P, Jaeheung K, et al. Focused ultrasound as a novel non-invasive method for the delivery of gold nanoparticles to retinal ganglion cells. 2024 May 1;13(5):5\u201315.","DOI":"10.1167\/tvst.14.1.13"},{"key":"3420_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102537","volume":"35","author":"M Sun","year":"2025","unstructured":"Sun M, Wang J, Fan W, Wang K, Wang Y, Zhang J, et al. From design to deployment: the innovative role of nanomicelles in targeted ophthalmic therapeutics. Mater Today Bio. 2025;35:102537. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102537.","journal-title":"Mater Today Bio"},{"key":"3420_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01992-2","volume":"21","author":"S Li","year":"2023","unstructured":"Li S, Chen L, Fu Y. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. J Nanobiotechnology. 2023;21:232. https:\/\/doi.org\/10.1186\/s12951-023-01992-2.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"3420_CR108","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1023\/A:1017962731813","volume":"103","author":"AH Shedden","year":"2001","unstructured":"Shedden AH, Laurence J, Barrish A, Olah TV. Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE\u00ae) once daily versus timolol maleate ophthalmic solution twice daily. Doc Ophthalmol. 2001;103(1):73\u20139.","journal-title":"Doc Ophthalmol"},{"key":"3420_CR109","doi-asserted-by":"crossref","unstructured":"Leibowitz HM, Chang RK, Mandell AI. Gel tears: a new medication for the treatment of dry eyes. Ophthalmology. 1984;91(10):1199\u2013204.","DOI":"10.1016\/S0161-6420(84)34173-2"},{"issue":"5","key":"3420_CR110","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/eye.1998.215","volume":"12","author":"AJ Bron","year":"1998","unstructured":"Bron AJ, Daubas P, Siou-Mermet R, Trinquand C. Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears. Eye. 1998;12(5):839\u201347.","journal-title":"Eye"},{"key":"3420_CR111","doi-asserted-by":"crossref","unstructured":"Montmeat D, Thouvenin A, Rasamison R, Boudy V. Physicochemical properties and rheological behavior of artificial tears for dry eye syndrome. J Ocul Pharmacol Ther. 2025;41(10):604\u201310.","DOI":"10.1177\/10807683251364169"},{"key":"3420_CR112","unstructured":"ClinicalTrials.gov. [Online]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02380248?cond=Dry%20Eye%20Disease&term=keratoconjunctivitis%20sicca%20or%20dry%20eye%20syndrome&intr=polymer&rank=7. Accessed Dec 2025."},{"key":"3420_CR113","unstructured":"Clinicaltrials.gov. [Online]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00545064?cond=Dry%20Eye%20Disease&term=keratoconjunctivitis%20sicca%20or%20dry%20eye%20syndrome&intr=Timolol%20Maleate&rank=1. Accessed Dec 2025."},{"key":"3420_CR114","unstructured":"ClinicalTrials.gov. [Online]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00932477?cond=Dry%20Eye%20Disease&term=keratoconjunctivitis%20sicca%20or%20dry%20eye%20syndrome&intr=biomedical&rank=3. Accessed Dec 2025."},{"key":"3420_CR115","unstructured":"CinicalTrials.gov. [Online]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02752763?cond=Dry%20Eye%20Disease&term=keratoconjunctivitis%20sicca%20or%20dry%20eye%20syndrome&intr=biomedical&rank=4. Accessed Dec 2025."},{"key":"3420_CR116","doi-asserted-by":"crossref","unstructured":"Ji Y, Liang J, Hei X, Chen L, Yu S, Fang D, et al. Nanomaterial-based drug delivery systems for ocular diseases: A review. Chin Chem Lett. 2025;4:112062.","DOI":"10.1016\/j.cclet.2025.112062"},{"key":"3420_CR117","doi-asserted-by":"crossref","unstructured":"Liu LC, Chen YH, Lu DW. Overview of recent advances in nano-based ocular drug delivery. Int J Mol Sci. 2023;24(20):15352.","DOI":"10.3390\/ijms242015352"},{"key":"3420_CR118","doi-asserted-by":"crossref","unstructured":"Sharma S, Sudhakara P, Singh J, Ilyas RA, Asyraf MR, Razman MR. Critical review of biodegradable and bioactive polymer composites for bone tissue engineering and drug delivery applications. Polymers. 2021;13(16):2623.","DOI":"10.3390\/polym13162623"},{"key":"3420_CR119","doi-asserted-by":"publisher","unstructured":"Sahoo S, Behera A, Acharya B, Patra D. Recent advances in eco-friendly bionanocomposites for drug delivery of natural bioactive compounds: a sustainable approach. Nano Trends. 2026 Jan 27:100188. https:\/\/doi.org\/10.1016\/j.nwnano.2026.100188.","DOI":"10.1016\/j.nwnano.2026.100188"},{"key":"3420_CR120","doi-asserted-by":"crossref","unstructured":"Lakeh MV, Kong YL, Leong MY, Looi CY. Dynamics of stimuli-responsive hydrogel-based nanocarriers in advanced drug delivery systems. Next Materials. 2026:11:101831.","DOI":"10.1016\/j.nxmate.2026.101831"},{"key":"3420_CR121","doi-asserted-by":"crossref","unstructured":"Bairagi RD, Reon RR, Hasan MM, Sarker S, Debnath D, Rahman MT, et al. Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases. Discover Nano. 2025;20(1):75.","DOI":"10.1186\/s11671-025-04234-6"},{"key":"3420_CR122","doi-asserted-by":"crossref","unstructured":"Mauri E, Giannitelli SM, Trombetta M, Rainer A. Synthesis of nanogels: Current trends and future outlook. Gels. 2021;7(2):36.","DOI":"10.3390\/gels7020036"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03420-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03420-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03420-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:09:14Z","timestamp":1780502954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03420-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":122,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["3420"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03420-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial or other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"186"}}